Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease

Published:2018-10-23 Issue:12 Volume:96 Page:1375-1385
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Seo Minseok,Qiu Weiliang,Bailey William,Criner Gerard J.,Dransfield Mark T.,Fuhlbrigge Anne L.,Reilly John J.,Scholand Mary Beth,Castaldi Peter,Chase Robert,Parker Margaret,Saferali Aabida,Yun Jeong H.,Crapo James D.,Cho Michael H.,Beaty Terri H.,Silverman Edwin K.,Hersh Craig P.^ORCID

Funder

National Heart, Lung, and Blood Institute

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/article/10.1007/s00109-018-1708-8/fulltext.html

Reference34 articles.

1. Nocturnal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 93:391–398

2. Medical Research Council Working Party (1981) Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1:681–686

3. Gorecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J (1997) Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 52:674–679

4. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R, Levi-Valensi P, Zielinski J, Delaunois L, Cornudella R et al (1999) A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 14:1002–1008

5. Drummond MB, Blackford AL, Benditt JO, Make BJ, Sciurba FC, McCormack MC, Martinez FJ, Fessler HE, Fishman AP, Wise RA (2008) Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial. Chest 134:497–506

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 spike protein-ACE2 interaction increases carbohydrate sulfotransferases and reduces N-acetylgalactosamine-4-sulfatase by p38 MAPK;Signal Transduction and Targeted Therapy;2024-02-14

2. Precision Approaches to Chronic Obstructive Pulmonary Disease Management;Annual Review of Medicine;2024-01-29

3. Omics methods predict the prognosis and treatment efficacy of chronic obstructive pulmonary disease;Chinese Medical Journal;2024-01-12

4. Severity of Lung Function Impairment Drives Transcriptional Phenotypes of COPD and Relates to Immune and Metabolic Processes;International Journal of Chronic Obstructive Pulmonary Disease;2023-03

5. SARS-CoV-2 Spike Protein Receptor Binding-ACE2 Interaction Increases Carbohydrate Sulfotransferases and Reduces N-Acetylgalactosamine-4-Sulfatase through Phospho-p38-MAPK and RB-E2F1;2023-01-28